Review the pathogenesis of asthma, including the role of biomarkers. |
|
|
|
|
|
|
Evaluate current and emerging targeted and biologic therapies for the treatment of moderate-to-severe asthma presented at CHEST 2016. |
|
|
|
|
|
|
Incorporate patient education into individualized treatment plans to improve patient adherence and overall quality of life for patients with moderate-to-severe asthma |
|
|
|
|
|
|